ConCallIQ
Go Pro
ELECTCAST Diversified 10 Feb 2026

Electrosteel Castings Limited — Q3 FY26

Electrosteel Castings reported a weak Q3 FY26 with consolidated total income of ₹1,526 crore and EBITDA of ₹88 crore (margin 5.8%), impacted by a 31% YoY drop in DI pipe sales volume to 1.34 lakh tonnes.

bearish high
Compare with...
Revenue ₹1,526 Cr
EBITDA ₹88 Cr
PAT ₹-22 Cr
EBITDA Margin 5.8%
Duration 60 min
Read Time 1 min read

Financial stats pending filing verification

2-Minute Summary

✦ AI-Generated from Full Transcript

Electrosteel Castings reported a weak Q3 FY26 with consolidated total income of ₹1,526 crore and EBITDA of ₹88 crore (margin 5.8%), impacted by a 31% YoY drop in DI pipe sales volume to 1.34 lakh tonnes. Domestic demand remained subdued due to a government spending freeze under Jal Jeevan Mission (JJM), though export volumes grew 11% QoQ. Management expects a gradual recovery from April 2026 as pending JJM funds (₹17,000 crore central share) are released. The company is diversifying into high-tech valves via an Italian acquisition. Key risk: sustained demand weakness if fund releases are further delayed, prolonging the current trough.

Risks4 trackedTranscriptfull text
Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

Delayed JJM fund release

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

DI pipe sales volume (Q3) 1.34 lakh tonnes
-31% YoY

Sales volume declined sharply due to domestic demand slowdown from government spending delays.

Export volume growth (QoQ) 11%
+11% QoQ

Export volumes increased quarter-on-quarter, partially offsetting domestic weakness.

Domestic market share ~20%
flat

Electrosteel holds around 20% of the domestic DI pipe market, similar to peers.

Net debt ₹812 crore
-455 crore QoQ

Net debt reduced significantly from previous quarter due to lower working capital requirements.

Fast read

Guidance and risk preview

Top guidance Q4 FY26 volumes similar to Q3

Management expects Q4 sales volume to be in line with Q3, with no immediate uptick.

Top risk Delayed JJM fund release

The ₹17,000 crore central share for JJM is pending cabinet approval; further delays could prolong demand weakness.

View Risks →